COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 309: Articles 3081-3090  | Next

Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort
Azeez, R., Lotoski, L., Winsor, G. L., Arnold, C. R., Galipeau, Y., Pelchat, M., Goguen, S., Simons, E., Moraes, T. J., Mandhane, P. J., Turvey, S. E., Bolotin, S., Patrick, D. M., Bullard, J., Lix, L. M., Doucas, N., Rodriguez, N., Brinkman, F. S. L., Subbarao, P., Langlois, M.-A., Azad, M.
10.1101/2023.09.06.23294696 — Posted: 2023-09-08
Uncovering the implications of IFN-I in severe COVID-19 neutrophil inflammasome
Cabrera, L. E., Jokiranta, S. T., Mäki, S., Miettinen, S., Kant, R., Kareinen, L., Sironen, T., Pietilä, J.-P., Kantele, A., Kekäläinen, E., Lindgren, H., Mattila, P., Kipar, A., Vapalahti, O., Strandin, T.
10.1101/2023.09.07.23295190 — Posted: 2023-09-08
Disease trajectories in hospitalized COVID-19 patients are predicted by clinical and peripheral blood signatures representing distinct lung pathologies.
Silva Filho, J. L., Herder, V., Gibbins, M. P., dos Reis, M. F. F., Melo, G. C., Haley, M., Judice, C. C., Val, F. F. A., Borba, M., Tavella, T. A., Sampaio, V. S., Attipa, C., McMonagle, F., de Lacerda, M. V. G., Costa, F. T. M., Couper, K. N., Monteiro, W. M., Ferreira, L. C. d. L., Moxon, C. A., Palmarini, M., Marti, M.
10.1101/2023.09.08.23295024 — Posted: 2023-09-08
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Khan, K., Lustig, G., Reedoy, K., Jule, Z., Romer, C., Karim, F., Ganga, Y., Bernstein, M., Baig, Z., Mahlangu, B., Mnguni, A., Nzimande, A., Stock, N., Kekana, D., Ntozini, B., van Deventer, C., Marshall, T., Manickchund, N., Gosnell, B., Lessells, R., Abdool Karim, Q., Abdool Karim, S. S., Moosa, Y., de Oliveira, T., von Gottberg, A., Wolter, N., Neher, R. A., Sigal, A.
10.1101/2023.09.08.23295250 — Posted: 2023-09-08
Early combination with remdesivir, nirmatrelvir/ritonavir and sotrovimab for the treatment of COVID-19 in immunocompromised hosts
Gentile, I., Foggia, M., Silvitelli, M., Sardanelli, A., Cattaneo, L., Viceconte, G., Federico II COVID team
10.1101/2023.09.07.23295202 — Posted: 2023-09-08
SARS-CoV-2 ORF8 modulates lung inflammation and clinical disease progression
Frieman, M., McGrath, M. E., Xue, Y., Taylor, L., Dillen, C., Ardanuy, J., Gonzalez-Juarbe, N., Baracco, L., Kim, R., Hart, R., Assad-Garcia, N., Vashee, S.
10.1101/2023.09.08.556788 — Posted: 2023-09-08
Stereotypic persistent B cell receptor clonotypes in Alzheimer's Disease
Yang, H., Kim, N., Lee, Y., Yoo, D. K., Choi, J., Kim, K., Bae, J., Han, J., Kwon, S., Chung, J.
10.1101/2023.09.07.554570 — Posted: 2023-09-08
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United States
Kohli, M., Maschio, M., Joshi, K., Lee, A., Fust, K., Beck, E., Van de Velde, N., Weinstein, M. C.
10.1101/2023.09.05.23295085 — Posted: 2023-09-07
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells
Zurlo, M., Gasparello, J., Verona, M., Papi, C., Cosenza, L. C., Finotti, A., Marzaro, G., Gambari, R.
10.1101/2023.09.07.556634 — Posted: 2023-09-07
SARS-CoV-2 ORF7a mutation found in BF.5 and BF.7 sublineages impacts its functions
Timilsina, U., Duffy, S., Plianchaisuk, A., Ito, J., Sato, K., Stavrou, S.
10.1101/2023.09.06.556547 — Posted: 2023-09-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).